[Federal Register Volume 87, Number 79 (Monday, April 25, 2022)]
[Notices]
[Pages 24322-24323]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-08716]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Special Topics: Vision Imaging, Bioengineering and Low Vision 
Technology Development.
    Date: May 25-26, 2022.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Susan Gillmor, Ph.D., Scientific Review Officer, 
National Institutes of Health, Center for Scientific Review, 6701 
Rockledge Drive, Bethesda, MD 20892, 240-762-3076, 
[email protected].

    Name of Committee: Bioengineering Sciences & Technologies 
Integrated Review Group; Gene and Drug Delivery Systems Study 
Section.
    Date: June 13-14, 2022.
    Time: 9:00 a.m. to 8:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Jain Krotz, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (240) 672-8670 
[email protected].

    Name of Committee: Vascular and Hematology Integrated Review 
Group; Hemostasis, Thrombosis, Blood Cells and Transfusion Study 
Section.
    Date: June 14-15, 2022.
    Time: 10:00 a.m. to 9:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Katherine M Malinda, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 
20892, (301) 435-0912, [email protected].

    Name of Committee: Bioengineering Sciences & Technologies 
Integrated Review Group; Instrumentation and Systems Development 
Study Section.

[[Page 24323]]

    Date: June 16-17, 2022.
    Time: 9:30 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Kee Forbes, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5148, MSC 7806, Bethesda, MD 20892, 301-272-
4865, [email protected].

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Cancer Biomarkers Study Section.
    Date: June 16-17, 2022.
    Time: 9:30 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD 
20892, 301-357-9318 [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: April 19, 2022.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-08716 Filed 4-22-22; 8:45 am]
BILLING CODE 4140-01-P